[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-338565-105":59,"doc-detail-338565-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","novel-artificial-intelligence-based-identification-of-drug-gene-disease-interaction-using-protein-protein-interaction-abstract","Novel artificial intelligence-based identification of drug-gene-disease interaction using protein-protein interaction - Abstract","","The evaluation of drug-gene-disease interactions is key to identifying drugs effective against disease. However, current approaches struggle to find drugs effective against genes that are critical for disease. A gene-centric strategy is easier, yet it is unclear how to identify gene sets without specifying either target diseases or drugs. This study proposes an unsupervised AI approach using tensor decomposition to enable drug repositioning from protein-protein interactions alone.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/novel-artificial-intelligence-based-identification-of-drug-gene-disease-interaction-using-protein-protein-interaction-abstract/338565/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/novel-artificial-intelligence-based-identification-of-drug-gene-disease-interaction-using-protein-protein-interaction-abstract/338565.png","ImageObject",300,407,{"name":92,"@type":93},"Genevieve","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-16","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What problem does the study address in drug repositioning?","Question",{"text":112,"@type":113},"It targets the difficulty of identifying drugs effective against disease-critical genes when drug-gene-disease relationships are complex and not simply pairwise.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does the proposed method avoid using information about diseases or drugs?",{"text":117,"@type":113},"It uses a gene-centric, unsupervised AI approach with tensor decomposition to extract features from protein-protein interactions without specifying diseases or drugs.",{"name":119,"@type":110,"acceptedAnswer":120},"Why were hub proteins used, and what limitation did they have?",{"text":121,"@type":113},"After replacing selected proteins with hub proteins, hub proteins enabled repositioning; however, they mainly identify cancer drugs, so other-disease identification requires the unsupervised feature extraction method.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},338565,1791072529,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":26,"preview_page_count":19,"preview_urls":145},1374391974585,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Taguchi and Turki BMC Bioinformatics (2024) 25:377 BMC Bioinformatics  \n[https://doi.org/10.1186/s12859-024-06009-9](https://doi.org/10.1186/s12859-024-06009-9)  \nRESEARCH Open Access  \nNovel artificial intelligence-based  \nidentification of drug-gene-disease interaction using protein-protein interaction  \nY.-h Taguchi1* and TurkiTurki2  \n*Correspondence: [tag@granular.com](tag@granular.com)  \n1 Department of Physics, Chuo University, 1-13-27 Kasuga, Bunkyo-ku, Tokyo 112-8551, Japan  \n2 Department of Computer Science, King Abdulaziz University, Jeddah 21589, Saudi Arabia  \nAbstract  \nThe evaluation of drug-gene-disease interactions is key for the identification of drugs effective against disease. However, at present, drugs that are effective against genes that are critical for disease are difficult to identify. Following a disease-centric approach, there is a need to identify genes critical to disease function and find drugs that are effective against them. By contrast, following a drug-centric approach comprises identifying the genes targeted by drugs, and then the diseases in which the identified genes are critical. Both of these processes are complex. Using a gene-centric approach, whereby we identify genes that are effective against the disease and can be targeted by drugs, is much easier. However, how such sets of genes can be identified without specifying either the target diseases or drugs is not known. In this study, a novel artificial intelligence-based approach that employs unsupervised methods and identifies genes without specifying neither diseases nor drugs is presented. To evaluate its feasibility, we applied tensor decomposition (TD)-based unsupervised feature extraction (FE) to perform drug repositioning from protein-protein interactions (PPI) without any other information. Proteins selected by TD-based unsupervised FE include many genes related to cancers, as well as drugs that target the selected proteins. Thus, we were able to identify cancer drugs using only PPI. Because the selected proteins had more interactions, we replaced the selected proteins with hub proteins and found that hub proteins themselves could be used for drug repositioning. In contrast to hub proteins, which can only identify cancer drugs, TD-based unsupervised FE enables the identification of drugs for other diseases. In addition, TD-based unsupervised FE can be used to identify drugs that are effective in in vivo experiments, which is difficult when hub proteins are used. In conclusion, TD-based unsupervised FE is a useful tool for drug repositioning using only PPI without other information.  \nKeywords: Protein-protein interaction, Drug repositioning, Artificial intelligence, Unsupervised learning, Tensor decomposition  \nIntroduction  \nThe identification of drug-gene-disease information is critical for drug repositioning. Nevertheless, due to the fact that this does not involve a simple identification of paired information but rather of triplet information, identifying drug-gene-disease information  \n© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.","cbCaijZbtLHXURbe","https://ap.wps.com/l/cbCaijZbtLHXURbe","pdf",2626200,24,"English","# Abstract\n# Introduction\n## Disease-centric vs drug-centric identification\n## Prior work on drug-gene-disease relationships","[{\"question\":\"What problem does the study address in drug repositioning?\",\"answer\":\"It targets the difficulty of identifying drugs effective against disease-critical genes when drug-gene-disease relationships are complex and not simply pairwise.\"},{\"question\":\"How does the proposed method avoid using information about diseases or drugs?\",\"answer\":\"It uses a gene-centric, unsupervised AI approach with tensor decomposition to extract features from protein-protein interactions without specifying diseases or drugs.\"},{\"question\":\"Why were hub proteins used, and what limitation did they have?\",\"answer\":\"After replacing selected proteins with hub proteins, hub proteins enabled repositioning; however, they mainly identify cancer drugs, so other-disease identification requires the unsupervised feature extraction method.\"}]","Novel artificial intelligence-based identification of drug-gene-disease interaction using protein-protein interaction - Abstract | PDF",1790024281,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6bb183d410272d179cd53f8b52222e32.webp",983,1305,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8823b1fe7cb81b4d604d32b1dc3115c2.webp",982,1304,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/276f052750a794f996bfe10fc436ead2.webp",981,1303,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2eb30a2129d395325e4c8811f3a97a8e.webp",980,1301]